Prelude Capital Management, LLC Bioventus Inc. Transaction History
Prelude Capital Management, LLC
- $1.5 Billion
- Q4 2024
A detailed history of Prelude Capital Management, LLC transactions in Bioventus Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 18,234 shares of BVS stock, worth $184,892. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,234
Previous 26,991
32.44%
Holding current value
$184,892
Previous $322,000
40.68%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding BVS
# of Institutions
158Shares Held
45.3MCall Options Held
252KPut Options Held
72.5K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$132 Million31.61% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$70.4 Million28.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.03MShares$40.8 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$25 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$24 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $625M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...